NCT05546372
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Amsterdam UMC location VUmc Amsterdam, Netherlands
Clinical trial condition
Perihilar Cholangiocarcinoma
Explore clinical trials studying Perihilar Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
12 public trials
6 recruiting studies
Perihilar Cholangiocarcinoma trial results
NCT06125769
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Azienda Ospedale Università di Padova Padova, PADOVA, Italy
Recruiting
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
NCT05430698
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
NCT04993131
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +13 more
- Locations
-
- Oslo university hospital Oslo, Norway
NCT06986486
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale Tumori di Milano Milan, Michigan, Italy
NCT06720883
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Azienda Ospedaliera di Padova Padova, Italy
Not Yet Recruiting
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
NCT07161869
- Conditions
- Adenocarcinoma, Adenocarcinoma of Biliary Tract, Bile Duct Diseases, +18 more
- Locations
-
- Erasmus MC University Medical Center Rotterdam, South Holland, Netherlands
NCT06923475
- Conditions
- Adenocarcinoma, Borderline Resectable, Carcinoma, +9 more
- Locations
-
- Amsterdam University Medical Center Amsterdam, Netherlands
NCT05874934
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Amsterdam UMC Amsterdam, Netherlands
NCT05024513
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Department of Interventional Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education),Peking University Cancer Hospital and Institute Beijing, China